Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Hansenpharm Co. Begins Selling Generic Zyprexa in China

publication date: Jul 9, 2007
Chinese Pharma Won Patent Suit in 2006 Jiangsu Hansen Pharmaceutical Co. Ltd, known as Hansenpharm Co., has started to sell its generic version of Zyprexa (olanzapine), an anti-psychotic used widely to treat schizophrenia that is a billion-dollar seller for Lilly (LLY). In late 2006, Hansenpharm won a five-year-long Chinese patent suit over the drug and its method of production. It was the first time a Chinese company prevailed in a patent infringement lawsuit against a major international biopharma. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital